We are a pharmaceutical company made up of 100% Spanish capital (50% owned by Gadea Pharmaceutical Group and the other 50% by Infarco, S.A.), dedicated to the manufacturing and development of highly active generic medicines such as hormonal products related to the field of women's health: hormonal contraception, endometriosis, hormone replacement therapy, infertility and hormone-dependent cancer treatments.
By having Gadea Pharmaceutical Group (a world leader in the field of steroids based active ingredients) involved within the ownership, we have the opportunity to capitalize on the advantages of vertical integration starting with the active ingredients all the way to the final pharmaceutical product.